Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Patrizio V, Bobbio-Pallavicini F, Pozzi E, Montecucco C: BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 111-118.
PubMed
Google Scholar
Witt C, Borges AC, John M, Fietze I, Baumann G, Krause A: Pulmonary involvement in diffuse cutaneous systemic sclerosis: bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis. Ann Rheum Dis. 1999, 58: 635-640. 10.1136/ard.58.10.635.
Article
PubMed Central
CAS
PubMed
Google Scholar
Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP, Black CM, du Bois RM, Wells AU: Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum. 2007, 56: 2005-2012. 10.1002/art.22696.
Article
PubMed
Google Scholar
Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith AE, Furst DE, Tashkin DP, Scleroderma Lung Study Research Group: Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008, 177: 91-98. 10.1164/rccm.200705-655OC.
Article
PubMed Central
CAS
PubMed
Google Scholar
Atamas SP, White B: Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev. 2003, 14: 537-550. 10.1016/S1359-6101(03)00060-1.
Article
CAS
PubMed
Google Scholar
Smith RE, Strieter RM, Zhang K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL: A role for C-C chemokines in fibrotic lung disease. J Leukoc Biol. 1995, 57: 782-787.
CAS
PubMed
Google Scholar
Distler O, Pap T, Kowal-Bielecka O, Meyringer R, Guiducci S, Landthaler M, Scholmerich J, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Muller-Ladner U: Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum. 2001, 44: 2665-2678. 10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S.
Article
CAS
PubMed
Google Scholar
Mattuzzi S, Barbi S, Carletto A, Ravagnani V, Moore PS, Bambara LM, Scarpa A: Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 2007, 34: 997-1004.
CAS
PubMed
Google Scholar
Granel B, Chevillard C, Allanore Y, Arnaud V, Cabantous S, Marquet S, Weiller PJ, Durand JM, Harle JR, Grange C, Frances Y, Berbis P, Gaudart J, de Micco P, Kahan A, Dessein A: Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics. 2006, 58: 693-699. 10.1007/s00251-006-0135-0.
Article
CAS
PubMed
Google Scholar
Simms RW, Korn JH: Cytokine directed therapy in scleroderma: rationale, current status, and the future. Curr Opin Rheumatol. 2002, 14: 717-722. 10.1097/00002281-200211000-00015.
Article
CAS
PubMed
Google Scholar
LeRoy EC, Medsger TA: Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001, 28: 1573-6.
CAS
PubMed
Google Scholar
Furst DE, Clements PJ, Steen VD, Medsger TA, Masi AT, D'Angelo WA, Lachenbruch PA, Grau RG, Seibold JR: The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998, 25: 84-88.
CAS
PubMed
Google Scholar
Warrick JH, Bhalla M, Schabel SI, Silver RM: High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991, 18: 1520-1528.
CAS
PubMed
Google Scholar
Haslam PL, Baughman RP: Report of ERS task force: guidelines for the measurement of acellular components and standardization of BAL. Eur Respir J. 1999, 14: 245-248. 10.1034/j.1399-3003.1999.14b01.x.
Article
CAS
PubMed
Google Scholar
American Thoracic Society: Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis. 1990, 142: 481-486. [Medline]
Article
Google Scholar
Krause A, Hohberg B, Heine F, John M, Burmester GR, Witt C: Cytokines derived from alveolar macrophages induce fever after bronchoscopy and bronchoalveolar lavage. Am J Respir Crit Care Med. 1997, 155: 1793-1797.
Article
CAS
PubMed
Google Scholar
Robinson BW, Rose AH, James A, Whitaker D, Musk AW: Alveolitis of pulmonary asbestosis: bronchoalveolar lavage studies in crocidolite- and chrysotile-exposed individuals. Chest. 1986, 90: 396-402. 10.1378/chest.90.3.396.
Article
CAS
PubMed
Google Scholar
Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Bobbio-Pallavicini F, Pozzi E, Montecucco C: Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia. Ann Rheum Dis. 2004, 63: 892-894. 10.1136/ard.2003.014019.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fietta A, Bardoni A, Salvini R, Passadore I, Morosini M, Cavagna L, Codullo V, Pozzi E, Meloni F, Montecucco C: Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther. 2006, 8: R160-10.1186/ar2067.
Article
PubMed Central
PubMed
Google Scholar
Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM: Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997, 40: 743-751. 10.1002/art.1780400422.
Article
CAS
PubMed
Google Scholar
Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pita O, Puddu P, Paganelli R, Russo G: Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol. 2004, 138: 540-546. 10.1111/j.1365-2249.2004.02642.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yamamoto T, Nishioka K: Role of monocyte chemoattractant protein-1 and its receptor, CCR-2, in the pathogenesis of bleomycin-induced scleroderma. J Invest Dermatol. 2003, 121: 510-516. 10.1046/j.1523-1747.2003.12408.x.
Article
CAS
PubMed
Google Scholar
Kimura M, Kawahito Y, Hamaguchi M, Nakamura T, Okamoto M, Matsumoto Y, Endo H, Yamamoto A, Ishino H, Wada M, Omoto A, Tsubouchi Y, Kohno M, Yoshikawa T: SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice. Biomed Pharmacother. 2007, 61: 222-228. 10.1016/j.biopha.2006.10.002.
Article
CAS
PubMed
Google Scholar
Distler JH, Jungel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, Michel BA, Muller-Ladner U, Kalden JR, Gay S, Distler O: Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum. 2006, 54: 214-225. 10.1002/art.21497.
Article
CAS
PubMed
Google Scholar
Lee EB, Zhao J, Kim JY, Xiong M, Song YM: Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis. Arthritis Rheum. 2007, 56: 2443-2448. 10.1002/art.22742.
Article
CAS
PubMed
Google Scholar
Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, Welsh K, Bunn C, Knight C, Foley P, du Bois RM: Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 2000, 43: 1633-1640. 10.1002/1529-0131(200007)43:7<1633::AID-ANR29>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Kadono T, Kikuchi K, Ihn H, Takehara K, Tamaki K: Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol. 1998, 25: 296-301.
CAS
PubMed
Google Scholar
Pantelidis P, Southcott AM, Black CM, Du Bois RM: Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis. Clin Exp Immunol. 1997, 108: 95-104. 10.1046/j.1365-2249.1997.d01-986.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S: Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. J Rheumatol. 2003, 30: 1524-1528.
CAS
PubMed
Google Scholar
Namen AE, Williams DE, Goodwin RG: Interleukin-7: a new hematopoietic growth factor. Prog Clin Biol Res. 1990, 338: 65-73.
CAS
PubMed
Google Scholar
Londei M, Verhoef A, Hawrylowicz C, Groves J, De Berardinis P, Feldmann M: Interleukin 7 is a growth factor for mature human T cells. Eur J Immunol. 1990, 20: 425-428. 10.1002/eji.1830200228.
Article
CAS
PubMed
Google Scholar
Appasamy PM: Interleukin-7: biology and potential clinical applications. Cancer Invest. 1993, 11: 487-499. 10.3109/07357909309018880.
Article
CAS
PubMed
Google Scholar
Roye O, Delacre M, Williams IR, Auriault C, Wolowczuk I: Cutaneous interleukin-7 transgenic mice display a propitious environment to Schistosoma mansoni infection. Parasite Immunol. 2001, 23: 133-140. 10.1046/j.1365-3024.2001.00365.x.
Article
CAS
PubMed
Google Scholar
Huang M, Sharma S, Zhu LX, Keane MP, Luo J, Zhang L, Burdick MD, Lin YQ, Dohadwala M, Gardner B, Batra RK, Strieter RM, Dubinett SM: IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest. 2002, 109: 931-937.
Article
PubMed Central
CAS
PubMed
Google Scholar
Highland KB, Silver RM: Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol Rep. 2005, 7: 135-141. 10.1007/s11926-005-0066-z.
Article
PubMed
Google Scholar
Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K: Soluble interleukin-2 receptors in patients with systemic sclerosis: clinical and laboratory correlations. Arthritis Rheum. 1990, 33: 375-380. 10.1002/art.1780330310.
Article
CAS
PubMed
Google Scholar
Martinez JA, Nishimura C, Guatura SB, Sato E, King TE: Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis. Rheumatol Int. 2001, 21: 122-126. 10.1007/s00296-001-0147-x.
Article
CAS
PubMed
Google Scholar
Segel MJ, Aqeilan R, Zilka K, Lorberboum-Galski H, Wallach-Dayan SB, Conner MW, Christensen TG, Breuer R: Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury. Int J Exp Pathol. 2005, 86: 279-288. 10.1111/j.0959-9673.2005.00436.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sharma SK, MacLean JA, Pinto C, Kradin RL: The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am J Respir Crit Care Med. 1996, 154: 193-200.
Article
CAS
PubMed
Google Scholar
Varga J, Pasche B: Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis. Curr Opin Rheumatol. 2008, 20: 720-728. 10.1097/BOR.0b013e32830e48e8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ihn H: Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci. 2008, 49: 103-113. 10.1016/j.jdermsci.2007.05.014. Epub 2007 Jul 12.
Article
CAS
PubMed
Google Scholar
Askew D, Zhou L, Wu C, Chen G, Gilliam AC: Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol. 2007, 127: 1905-1914. 10.1038/sj.jid.5700813. Epub 2007 Apr 12
Article
CAS
PubMed
Google Scholar
Wilson MS, Wynn TA: Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009, 2: 103-121. 10.1038/mi.2008.85. Review.
Article
PubMed Central
CAS
PubMed
Google Scholar
Witt C, Borges AC, John M, Fietze I, Baumann G, Krause A: Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis. Ann Rheum Dis. 1999, 58: 635-640. 10.1136/ard.58.10.635.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kowal-Bielecka O, Kowal K, Highland KB, Silver RM: Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum. 2009.
Google Scholar